FindTrial
Sign In

Treatment of Hyperlipedemia with Unani formulation

Clinical trial on Hyperlipidemia (Kasrat-e-Shahmuddam) with UNIM-763 - KSD/HL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013864
Enrollment
60
Registered
2018-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified Health Condition 2: null- Hyperlipidemia

Interventions

Intervention1: UNIM-763: 2 capsule of 500 mg each twice a day after meals: 2 capsule of UNIM 763, 500 mg each given twice a day after meals Control Intervention1: NIl: Nil

Sponsors

Central Council for Research in Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Serum cholesterol : > 200 mg/dl 2. Serum Triglycerides : >150 mg / dl 3. LDL : > 115 mg/ dl 4. HDL : > 40 5. Patient should be willing to cooperate the study protocol 6. Patient should be give written informed consent 7. Patient should not have any other disease.

Exclusion criteria

Exclusion criteria: 1. Un control diabetes mellitus 2. History of IHD 3. History of drug/alcohol abuse 4. Non cooperative patients.

Design outcomes

Primary

MeasureTime frame
Reduction of Serum Cholesterol and Serum TriglyceridesTimepoint: Baseline, 1st month, 2nd month, 3rd month—

Secondary

MeasureTime frame
Safety with Pathological and biochemical testsTimepoint: Before and after treatment—

Countries

India

Contacts

Public ContactDr Ahmed Minhajuddin

Central Research Institute of Unani Medicine

drmunawwar@yahoo.com9030168455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026